Cvetkovski, Biljana
Kritikos, Vicky
Yan, Kwok
Bosnic-Anticevich, Sinthia
Article History
Received: 20 August 2017
Revised: 9 November 2017
Accepted: 2 January 2018
First Online: 23 January 2018
Competing interests
: S.B.A. is a member of the Teva Pharmaceuticals Devices International Key Experts Panel, has received research support from Research in Real Life, has received lecture fees and payment for developing educational presentations from Teva and Mundipharma; and has received Honoraria from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, for her contribution to advisory boards/key international expert forum. V.K. has received honoraria from AstraZeneca, GlaxoSmithKline and Pfizer. K.Y. has received honoraria for speaking and consulting from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Meda, Mundipharma and Pfizer. The author declares no competing financial interests.